Morgan Stanley Maintains Overweight on argenx, Lowers Price Target to $1130

Benzinga · 19h ago
Morgan Stanley analyst Sean Laaman maintains argenx (NASDAQ:ARGX) with a Overweight and lowers the price target from $1190 to $1130.